This latest research on non-dystrophic myotonia offers promising results for those affected by the condition. Published in ...

The study, published in Lancet Neurology, detailed the "head-to-head" trial implemented by the researchers to test two drugs, ...

A UCL study found that lamotrigine is as effective as mexiletine for treating non-dystrophic myotonia, a rare muscle disorder ...

Lamotrigine, commonly used for epilepsy and mood disorders, has shown promise as a treatment for non-dystrophic myotonia, a ...

A study tested the effectiveness of mexiletine and lamotrigine in treating non-dystrophic myotonia. Results indicated that ...

Avidity Biosciences excels in antibody oligonucleotide conjugates with its stock tripling in the past year due to innovative ...

Lamotrigine, a drug commonly used to treat epilepsy and certain mood disorders, has been shown to be an excellent treatment option for a rare genetic neuromuscular disease known as non-dystrophic ...

The study, published in Lancet Neurology, detailed the "head-to-head" trial implemented by the researchers to test two drugs, ...

A common drug used to treat epilepsy and certain mood disorders, called lamotrigine, has shown great promise as a new ...

Lamotrigine, a drug commonly used to treat epilepsy and certain mood disorders, has been shown to be an excellent treatment option for a rare genetic ...

Our Bureau, Mumbai Friday, September 27, 2024, 16:15 Hrs [IST] ...

Mumbai: Global pharma major, Lupin Limited has announced that its subsidiary Lupin Atlantis Holdings SA has entered into a ...